Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Nextmune in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.
Mandate

Vinge advised Nextmune in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

October 08, 2020 Banking and Finance M&A

Vinge has advised Fidelio Capital and its portfolio company Nextmune, a leading science driven, global specialty pharmaceutical company dedicated to improving health for dogs, cats and horses, in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

Vinge’s team consisted of, among others, Jonas Bergström, Matthias Pannier, Maria Dahlin-Kolvik, Karl Klackenberg, Manne Bergström, Vilhelm Rondahl and Albert Wållgren, Josefine Lanker, Axel Jansson och Jolinn Uhlin.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026